Hot Keywords
metabolic syndrome kidney atherosclerosis endocrine disorder NAFLD diabetes MAFLD adipose tissue obesity obesity metabolism fatty liver steatosis fibrosis cardiovascular insulin resistance hypertension metabolomics precision medicine hypertriglyceridemia

Top

Announcement of Metabolism and Target Organ Damage Best Paper Award 2022

Published on: 21 Apr 2022 Viewed: 531

We are pleased to announce the "Metabolism and Target Organ Damage Best Paper Award 2022" has been established, which aims to recognize and promote high-quality contributions to academic research. Papers (Original Articles and Review Articles) submitted to Metabolism and Target Organ Damage from May 1, 2021, to December 31, 2022, will be considered. One article will be selected for this award after a thorough evaluation by the journal's Scientific Committee and under the guidance of the whole Editorial Board team. The winner will be announced in September 2023.

"The Best Paper" will be evaluated comprehensively from following three aspects: the review report submitted by reviewers, the comprehensive evaluation by the Editorial Board team, and the number of citations (searched by Google Scholar). It should be noted that, all members of our Editorial Board will not participate in the selection of papers from the same University/institution.

We encourage authors to focus on the following factors:
Innovation; Significance to the research community; Scientific impact; Technical excellence

Timeline:
Submission date: May 1 2021 to December 31, 2022;
Publication date: before March 31, 2023;
Winner(s) announcement: by the end of September 2023.

Winner(s) will be entitled to:
(1) $1000;
(2) An official award certificate with the name of the award, the title of the paper, and the name(s) of the author(s);
(3) The research achievements will be broadly promoted through all platforms of Metabolism and Target Organ Damage and OAE Publishing Inc.
(4) Winner(s) will be invited as the Chair or Guest Speakers to our journal webinars. The webinar will be held via Zoom and it could be broadcast live on Youtube and the Chinese WeChat Official Account, Video Account, Bilibili;
(5) A special interview will be provided to winner(s) and the interview will be promoted on the journal homepage, all media promotion platforms of both journals and our publisher.

Journal Website
https://mtodjournal.net
Make a Contribution
https://oaemesas.com/login?JournalId=mtod
Editorial Office
Ms. Doreen Deng
editorialoffice@mtodjournal.net

Metabolism and Target Organ Damage (M&TODhttps://mtodjournal.net/, ISSN: 2769-6375) is a journal newly launched in 2021 with fast development in the past few months. It is an international, peer-reviewed, open access interdisciplinary journal which provides an online platform for the publication of clinical, basic, and translational studies. It covers (cardio)-metabolic disorders per se, such as obesity, diabetes, dyslipidemias, arterial hypertension and hyperuricemia in all age groups.
Aims and Scope: https://mtodjournal.net/pages/view/aims_and_scope
Published Articles: https://mtodjournal.net/journal/archives

Editorial Board team:
Amedeo Lonardo, Tutor for fellows in Internal Medicine at the University of Modena and Reggio Emilia, has been placed in the top 0.012% of scholars about“fatty liver”in the world over the past 10 years (Expertscape);
Giovanni Targher, Coordinator of the PhD program of the University of Verona Medical School, has been placed in the top 0.003% of scholars about “fatty liver” in the world over the past 10 years (Expertscape);
Christopher Byrne, Chair of Endocrinology & Metabolism at the University of Southampton, the UK expert Diabetologist advisor to the National Institute for Health and Care Excellence (NICE) NAFLD Guidelines;
Leonardo M. Fabbri, Member of the Academy of Europe, Eminent Scholar of Internal and Respiratory Medicine, Department of Morphology, Surgery and Experimental Medicine, Section of Respiratory Diseases, University of Ferrara;
Helena Cortez-Pinto, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal. First female Vice President of United European Gastroenterology;
Malu Martínez-Chantar, Coordinator of the Translational Area of the National Institute for the Study of Liver and Gastrointestinal Diseases (CIBEREHD) and the Scientific Advisory Board of the Molecular Medicine Center C3M Nice and IDIVAL;
Laura E. Nagy, MERIT award from NIH and principal investigator for the Northern Ohio Alcohol Research Center. Past Chair of the Board of Scientific Counselors and current Advisory Council member for the National Institutes of Alcoholism and Alcohol Abuse;
etc.
The full list could be found via https://mtodjournal.net/editorsChief/index, https://mtodjournal.net/editorsYouth/index


© 2016-2022 OAE Publishing Inc., except certain content provided by third parties